These results support that the inhibition of CD38 by 78c is a promising therapeutic approach to treat older patients with periodontitis to inhibit periodontal inflammation, attenuate alveolar bone resorption, alleviate oxidative stress, and prolong the health span of human beings. Here, CD38 is linked to periodontitis.